The Clinical Significance of Schistocytes: A Prospective Evaluation of the International Council for Standardization in Hematology Schistocyte Guidelines
Turkish Journal of Hematology · 01.03.2017 · 34 (1) · 59-63
DOI: 10.4274/tjh.2016.0359 ↗Kurz gefasst
Leitlinie in der Zeitschrift Turkish Journal of Hematology, online erschienen am 01.03.2017. Verfasst von Elise Schapkaitz und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Witwatersrand Medical School, Department of Molecular Medicine and Hematology, Johannesburg, South Africa Phone: +27824592238 E-mail: e…. Die Arbeit wurde bisher 38-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Witwatersrand Medical School, Department of Molecular Medicine and Hematology, Johannesburg, South Africa Phone: +27824592238 E-mail: elise.schapkaitz@nhls.ac.za.
Zitieren
APA
Schapkaitz, E., & Mezgebe, M. H. (2017). The Clinical Significance of Schistocytes: A Prospective Evaluation of the International Council for Standardization in Hematology Schistocyte Guidelines. Turkish Journal of Hematology, 34(1), 59-63. https://doi.org/10.4274/tjh.2016.0359
Vancouver
Schapkaitz E, Mezgebe MH. The Clinical Significance of Schistocytes: A Prospective Evaluation of the International Council for Standardization in Hematology Schistocyte Guidelines. Turkish Journal of Hematology. 2017;34(1):59-63. doi:10.4274/tjh.2016.0359
BibTeX
@article{Schapkaitz2017,
author = {Schapkaitz, Elise and Mezgebe, Michael Halefom},
title = {The Clinical Significance of Schistocytes: A Prospective Evaluation of the International Council for Standardization in Hematology Schistocyte Guidelines},
journal = {Turkish Journal of Hematology},
year = {2017},
volume = {34},
number = {1},
pages = {59--63},
doi = {10.4274/tjh.2016.0359}
}
EUVIMED